Filter
409
Filtered Results: 409
Text search:
National
TB
Control
Programme,
Bangladesh
Featured
Recommendations
41
New Publications
112
Language
Document type
No document type
254
Studies & Reports
80
Guidelines
35
Manuals
16
Strategic & Response Plan
10
Situation Updates
5
Training Material
3
Resource Platforms
2
Infographics
2
Fact sheets
2
Countries / Regions
Bangladesh
43
Global
23
Asia
21
Nepal
19
South–East Asia Region
18
India
16
Myanmar / Burma
14
South Africa
6
Africa
5
Western and Central Europe
5
Uganda
5
Pakistan
5
Latin America and the Carribbean
4
Thailand
3
Rwanda
3
Nigeria
3
Malawi
3
Sri Lanka
3
Ethiopia
3
Kenya
2
Albania
2
Afghanistan
2
Zimbabwe
2
Philippines
2
Cambodia
2
Eastern Europe
2
Papua New Guinea
2
Georgia
2
Bhutan
2
Indonesia
2
North Macedonia
1
Tajikistan
1
North Korea
1
Colombia
1
Timor Leste/ East Timor
1
Sierra Leone
1
Syria
1
Iran
1
Laos
1
Senegal
1
Peru
1
Morocco
1
Mozambique
1
Haiti
1
Tanzania
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Tunisia
1
East and Southern Africa
1
Lebanon
1
Vietnam
1
Russia
1
Namibia
1
Sudan
1
Greece
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
115
Public Health
33
Clinical Guidelines
31
Women & Child Health
16
Key Resources
7
Pharmacy & Technologies
7
Capacity Building
6
Toolboxes
TB
118
HIV
44
COVID-19
24
Global Health Education
17
NTDs
14
Caregiver
12
AMR
12
Disability
9
Planetary Health
9
Rapid Response
8
Refugee
7
Health Financing Toolbox
7
Mental Health
6
Pharmacy
6
NCDs
6
Polio
4
Ebola
3
Natural Hazards
2
Conflict
2
Specific Hazards
1
Cholera
1
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, including Pakistan owing to the “misuse and overuse” of Antimicrobials, contributing to the increasing ...
treat TB
Description of Research Outputs, 2009 - 2014
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
Public Health Situation Analysis and Interventions 10 October 2017
Lessons from the STEP-TB Project.
Accessed November 2017.
On the road to ending TB
Highlights from the 30 highest TB burden countries
Asylum and Migration Working Paper 1
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
PeerJ PrePrints , http://dx.doi.org/10.7287/peerj.preprints.579v1 2 Nov 2014
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
Public Health Action PHA 2017; 7(2): 110–115
